Cargando…
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997928/ https://www.ncbi.nlm.nih.gov/pubmed/32099370 http://dx.doi.org/10.2147/NDT.S246085 |
| _version_ | 1783493782500540416 |
|---|---|
| author | Wang, Sheng-jun Liu, Xue-wu |
| author_facet | Wang, Sheng-jun Liu, Xue-wu |
| author_sort | Wang, Sheng-jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6997928 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69979282020-02-25 CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] Wang, Sheng-jun Liu, Xue-wu Neuropsychiatr Dis Treat Response to Letter Dove 2020-01-30 /pmc/articles/PMC6997928/ /pubmed/32099370 http://dx.doi.org/10.2147/NDT.S246085 Text en © 2020 Wang and Liu. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Response to Letter Wang, Sheng-jun Liu, Xue-wu CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title | CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_full | CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_fullStr | CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_full_unstemmed | CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_short | CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter] |
| title_sort | cxcl13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients [response to letter] |
| topic | Response to Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997928/ https://www.ncbi.nlm.nih.gov/pubmed/32099370 http://dx.doi.org/10.2147/NDT.S246085 |
| work_keys_str_mv | AT wangshengjun cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsresponsetoletter AT liuxuewu cxcl13isabiomarkerofantileucinerichgliomainactivatedprotein1encephalitispatientsresponsetoletter |